Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nathalie Adda currently holds 47,191 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nathalie Adda has been a net seller of ENTA stock. They have purchased $0 and sold $15.8M worth of shares.
Nathalie Adda's most recent insider trade was on Apr 4, 2022, when they sold 18,076 shares at $71.71 per share.
Nathalie Adda serves as Executive at ENANTA PHARMACEUTICALS INC (ENTA). They have executed 89 insider transactions totaling $15.8M over their tenure at the company.
Nathalie Adda holds the position of Executive at ENANTA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Nathalie Adda has shown a selling trading pattern, with $0 in total purchases and $15.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nathalie Adda was on Apr 1, 2022, when they sold $3.0M worth of ENTA shares. This transaction involved 42,260 shares at $71.32 per share.
Nathalie Adda currently owns 47,191 shares of ENANTA PHARMACEUTICALS INC (ENTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nathalie Adda's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nathalie Adda has 89 Form 4 filings on record as an insider at ENANTA PHARMACEUTICALS INC.
Set alerts for Nathalie Adda and 40,000+ other insiders.